Testing a Biometric Identification System to Improve Malaria Vaccine Completion
Recruiting
N/A
Interventional Study
Vaccination
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 15 – 49
- Sex
- Female
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 4,715 (estimated)
- Sponsor
- University of Michigan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Receiving all four doses of the malaria vaccine can significantly protect children against malaria illness, hospitalization, and death. However, in Ghana, only 46% of children complete the full vaccination sequence. More broadly, many children in Ghana do not receive the full set of recommended pediatric vaccinations. To address this, Simprints, in collaboration with Ghana Health Services, will im…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pregnant women (in the last two trimesters), aged 15-49 years old, who do not plan to permanently move in the next 12 months.
* Women with children under 6 months old, aged 15-49 years old, who do not plan to permanently move in the next 12 months.
Exclusion Criteria:
* Non-…
Contacts